Skip to main content
Clinical Trials/ITMCTR2024000034
ITMCTR2024000034
Completed
Early Phase 1

A randomized controlled study on the treatment of severe acute pancreatitis with intraperitoneal hypertension through nasogastric nutrition tube administration of Gansui

Guangdong Provincial Hospital of Chinese Medicine0 sitesTBD

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Guangdong Provincial Hospital of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Meets the diagnostic criteria for moderate severe acute pancreatitis or severe acute pancreatitis (refer to the 2021 edition of Chinese Guidelines for Diagnosis and Treatment of Acute Pancreatitis);
  • (2\) Gansui can be administered through a nasojejacual nutrition tube;
  • (3\) Voluntarily participate in this study and sign an informed consent form;
  • (4\) Age \= 18 and \= 75 years old, regardless of gender.

Exclusion Criteria

  • (1\) No gastrointestinal administration route;
  • (2\) Have a history of major digestive surgery in the past;
  • (3\) Patients who are currently participating in or have participated in other clinical trials within the month prior to this study;
  • (4\) Allergic reactions to therapeutic drugs;
  • (5\) Patients with fertility requirements or those who are pregnant or breastfeeding;
  • (6\) Liver function: Child Pugh C\-grade;
  • (7\) Kidney function: CKD stage 4 or 5\.

Outcomes

Primary Outcomes

Not specified

Similar Trials